History

Resumption of Priority Phase in Patent Interference Proceeding Between ToolGen and Broad Institute

Certified as a Family-Friendly Company 2025 / Ministry of Gender Equality and Family

CRISPR Gene Editing Technology License-out Agreement / Avinnogen Co., Ltd.

Selected as an Outstanding Work-Life Balance Company of Korea 2025 / Ministry of Employment and Labor

Execution of a Cross-License Agreement for In Vivo Gene Editing Therapeutics / GenEditBio (Hong Kong)

CRISPR Gene Editing Technology License-out Agreement / Hobs Bioscience Co., Ltd.

Change of Chief Executive Officer (ByungHwa Lee → JongSang Ryu)

Designated as a Leading Technology Protection Company / Ministry of SMEs and Startups

CRISPR Gene Editing Technology License-out Agreement / Organoid Sciences Co., Ltd.

Prime Minister’s Commendation at the 2024 Korea SMEs Conference Awarded to ToolGen CEO Byung Hwa Lee / Korea Federation of SMEs, Ministry of SMEs and Startups

ToolGen R&D Center Designated as an Outstanding Corporate Research Institute (First Half of 2024) / Ministry of Science and ICT

CRISPR Gene Editing Technology License-out Agreement / Bioseed Research India, a Unit of DCM Shriram Ltd.

Registration of a Foundational CRISPR Gene Editing Technology Patent in Canada / Canadian Intellectual Property Office

TGT-001 Gene Editing Therapy for CMT1A Granted Orphan Drug Designation (ODD) / U.S. Food and Drug Administration (FDA)

CRISPR Gene Editing Technology License-out Agreement / NoolaBio

Execution of a Patent License Agreement for CRISPR Gene Editing Technology / U.S. Biotechnology Company

Completion of the Osong R&D Center

Publication of Research on a Novel CRISPR-Cas9 Gene Editing Technology with Improved Specificity While Maintaining Efficacy / Nature Chemical Biology

Publication of Research Achieving the World’s First Standardized Genome-wide Off-Target Prediction / Genome Biology

Publication of Research on Off-Target Prediction of Gene Editing Technology / Nature Communications

Approval of GMO Regulation Exemption for Gene-Edited Browning-Resistant Potato Variety / U.S. Department of Agriculture (USDA)

CRISPR-Cas9 Gene Editing Technology Patent Interference Proceeding Motion Phase Victory (Senior Party Status Confirmed) / U.S. Patent Trial and Appeal Board (PTAB)

Relocation of Headquarters (8F, 172 Magokjungang-ro, Gangseo-gu, Seoul)

Listed on KOSDAQ / Korea Exchange

Registration of Foundational CRISPR Gene Editing Technology Patent in India / Indian Patent Office

Initiation of CRISPR-Cas9 Gene Editing Technology Patent Interference Proceeding / U.S. Patent Trial and Appeal Board (PTAB)

Registration of Foundational CRISPR Gene Editing Technology Patent in the United States / U.S. Patent and Trademark Office (USPTO)

Registration of Australian Patent for Campylobacter jejuni (C. jejuni)-Derived CRISPR-Cas9

Registration of Foundational CRISPR Gene Editing Technology Patent in Hong Kong / Hong Kong Intellectual Property Department

Non-GMO Determination (‘Am I Regulated?’) for Gene-Edited High-Oleic Soybean / U.S. Department of Agriculture (USDA)

Non-GMO Determination (‘Am I Regulated?’) for Gene-Edited Petunia Co-Developed with Chungnam National University / U.S. Department of Agriculture (USDA)

Registration of U.S. Patent for Campylobacter jejuni (C. jejuni)-Derived CRISPR-Cas9 / U.S. Patent and Trademark Office (USPTO)

Publication of Research on Gene Editing Technology for Charcot-Marie-Tooth Disease Type 1A (CMT1A) / Nucleic Acids Research

Registration of Foundational CRISPR Gene Editing Technology Patent in Japan / Japan Patent Office

Registration of Foundational CRISPR Gene Editing Technology Patent in Singapore / Intellectual Property Office of Singapore (IPOS)

Registration of Foundational CRISPR Gene Editing Technology Patent in Europe / European Patent Office (EPO)

Publication of Research on Enhanced CAR-T Therapy (Styx-T) / Cancer Research

Publication of Research on High-Specificity CRISPR Gene Editing Technology (Sniper Cas9) / Nature Communications

Registration of U.S. Patent for Gene Editing Reporter Technology / U.S. Patent and Trademark Office (USPTO)

License-Out of CRISPR Gene Editing Technology / Monsanto (now Bayer)

Approval of Australian Patent Registration for Foundational CRISPR Gene Editing Technology / IP Australia

License-Out of CRISPR Gene Editing Technology / Thermo Fisher Scientific (USA)

Listed on KONEX / Korea Exchange

License-Out of CRISPR Gene Editing Technology / KeyGene (Netherlands)

Publication of Human Genome TALEN Library Research / Nature Biotechnology

License-Out of CRISPR Gene Editing Technology / Life Technologies (USA)

Provisional Patent Application for Foundational CRISPR Gene Editing Technology / U.S. Patent and Trademark Office (USPTO)

Publication of Research on Gene Editing Mass Production Technology / Nature Methods

Publication of Research on Gene Editing Technology (Genome Deletion) / Genome Research

Publication of Research on Gene Editing Technology for AIDS Therapy / Genome Research

Selected as One of the Top 8 Global Research Achievements / Ministry of Science and Technology

Director Dr. Jin-Soo Kim Awarded Scientist of the Month / Ministry of Science and Technology, Korea Science Foundation

Publication of ZFP (Zinc Finger Proteins) Research / Nature Biotechnology

Selected as One of Asia’s 10 Most Promising Life Science Companies / Pacific Forum

Establishment of ToolGen Co., Ltd. (Head Office: 267-30 Sadang 4-dong, Dongjak-gu, Seoul)